Quarterly report pursuant to Section 13 or 15(d)

STOCK OPTIONS (Details 1)

v3.22.1
STOCK OPTIONS (Details 1)
3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Number of Shares  
Outstanding, Beginning | shares 815,351
Grants | shares 16,727
Outstanding, Ending | shares 832,078
Exercisable at Ending | shares 831,138
Weighted Average Exercise Price  
Outstanding, Beginning | $ / shares $ 7.85
Grants | $ / shares 3.89
Oustanding, Ending | $ / shares 7.77
Exercisable at Ending | $ / shares $ 7.78
Weighted Average Remaining Contractual Term  
Outstanding, Beginning 4 years 10 months 24 days
Grants 4 years 8 months 12 days
Outstanding at Ending 4 years 8 months 12 days
Exercisable at Ending 4 years 8 months 12 days
Aggregate Intrinsic Value  
Outstanding, Beginning | $ $ 795,115
Outstanding at Ending | $ 514,706
Exercisable at Ending | $ $ 514,706